TrialNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2016

Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial.

Ron T Gansevoort et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.